A Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsules in Chinese Patients With Type I Neurofibromatosis

Clinical trial NCT05011019 · TERMINATED

Trial details

NCT number: NCT05011019
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neurofibromatosis and Malignant Peripheral Nerve Sheath Tumors

Start date: 2021-09-07
Primary completion: 2024-02-02
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.